Regional distribution of cytochrome P450 2D1 in the rat central nervous system

Journal of Comparative Neurology

Volumn 366, Issue 2, 1996, Pages 244-258

  Norris, P J ^a   Hardwick, J P ^b   Emson, P C ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

catecholamine metabolism; neurotoxin; Parkinson's disease; polymorphism; xenobiotics

Indexed keywords

CYTOCHROME P450; NEUROTOXIN;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE METABOLISM; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHROMOSOME POLYMORPHISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; IMMUNOREACTIVITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; XENOBIOTIC METABOLISM;

ANIMALS; BLOTTING, NORTHERN; BRAIN; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIXED FUNCTION OXYGENASES; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR; RNA, MESSENGER; SPINAL CORD;

EID: 0030053243     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19960304)366:2<244::AID-CNE5>3.0.CO;2-5     Document Type: Article

References (48)

1. 3H]GBR-12935 binding to Cytochrome P450 in the human brain. J. Neurochem. 62:342-348.
2. Anandatheerthavarada, H.K., S.K. Shankar, and V. Ravindranath (1990) Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms. Brain Res. 536:339-343.
3. 3H] GBR-12935 binding in vitro to rat striatal membranes: labelling of the dopamine uptake complex. J Neurochem. 48.1887-1896.
4. Armstrong, M., A.K. Daly, S. Cholerton, D.N. Bateman, and J.R. Idle (1992) Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339:1017-1018.
5. Barbeau, A., M. Roy, S Paris, T. Cloutier, L. Plasse, and J. Poirier (1985) Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 2:1213-1216
6. Bhamre, S., H.K. Anandatheerathavarada, S.K. Shankar, M.R. Boyd, and V Ravindranath (1993) Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. Arch. Biochem Biophys 301 251-255.
7. Black, S.D. (1992) Membrane topology of the mammalian P450 cytochromes. FASEB J. 6:680-681.
8. Cholerton, S., A K. Daly, and J.R. Idle (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol. Sci. 13:434-439.
9. Chomczyski, P , and N. Sacchi (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162:156-159.
10. Ferrari, M D., F.A. DeWolff, P Vermey, H. Veenema, and O.J.S. Buruma (1986) Hepatic eytochrome-P450 malfunction and Parkinson's disease. Lancet 1:324.
11. Fonne-Pfister, R., M.J. Bargetzi, and U.A. Meyer (1987) MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufl, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem. Biophys Res. Commun. 148:1144-1150.
12. Ghersi-Egea, J -F., R. Perrin, B Leinmger-Muller, M.-C. Grassiot, C. Jeandel, J. Floquet, G. Cuny, G. Siest, and A. Minn (1993) Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem. Pharmacol. 45:647-658.
13. Giros, B., and M.G. Caron (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:43-49.
14. Gonzalez, F. J. (1989) The molecular biology of cytochrome P450s. Pharmacol. Rev. 40:243-288
15. Gonzalez, F.J., T. Matsunaga, K. Nagata, U.A. Meyer, D.W. Nebert, J. Pastewka, C.A. Kozak, J. Gillette, H.V. Gelboin, and J.P. Hardwick (1987) Debrisoquine 4-hydroxylase: Characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 6:149-161.
16. Gonzalez, F.J., R C. Skoda, S. Kimura, M. Umeno, U.M. Zanger, D.W. Nebert, H.V. Gelboin, J.P Hardwick, and U.A. Meyer (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331.442-446.
17. 450 CYP2D locus. Nature 347:773-776.
18. Guengerich, F. P. (1992) Human cytochrome P-450 enzymes. Life Sci. 50.1471-1478.
19. Hadley, W.M., and A R. Dahl (1982) Cytochrome P-450 dependent monooxygenase activity in rat nasal epithelial membranes. Toxicol. Lett. 10:417-422.
20. Haglund, L., C. Kohler, T. Haaparanta, M. Goldstein, and J.-Å. Gustafsson (1984) Presence of NADPH-cytochrome P450 reductase in central catecholammergic neurones. Nature 307.259-262.
21. Hansson, T., N. Tindberg, M. Ingelman-Sundberg, and C. Köhler (1990) Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system. Neuroscience 34:451-463.
22. 3H]GBR-12935 binding sites in human striatal membranes, binding charateristics and changes in parkinsonians and schizophrenics. Jpn J. Pharmacol 47:237-243.
23. Hodgson, A.V., T.B. White, J.W. White, and H.W. Strobel (1993) Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction. Mol. Cell. Biochem. 120:171-179.
24. Hsu, S.M., L. Raine, and H Fanger (1982) The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedure. J. Histochem Cytochem 59:577-580.
25. Iscan, M., K Reuhl, B. Weiss, and M.D. Maines (1990) Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: The olfactory bulb and the mitochondrial fraction have high levels of activity. Biochem. Biophys. Res. Commun. 169:858-863
26. Kadowaki, K., J. Kishimoto, G. Leng, and P.C. Emson (1994) Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology 134:1011-1017.
27. Kapitulnik, J., H.V. Gelboin, F.P Guengerich, and D.M. Jacobowitz (1987) Immunohistochemical localization of cytochrome P-450 in rat brain. Neuroscience 20:829-833.
28. Köhler, C., L.G. Eriksson, T. Hansson, M. Warner, and J.-Å. Gustafsson (1988) Immunohistochemical localization of cytochrome P-450 in the rat brain. Neurosci Lett. 84:109-114
29. Komori, M. (1993) A novel P450 expressed at the high level in rat brain. Biochem. Biophys. Res. Commun. 196:721-728.
30. Lledó, P. (1993) Variations in drug metabolism due to genetic polymorphism. A review of the debrisoquine/sparteme type Drug Invest. 5:19-34.
31. 3H]GBR-12935 binding to dopamine uptake sites in the human brain. Brain Res. 457:122-129.
32. Nebert, D.W., D.R. Nelson, M.J. Coon, R.W. Estabrook, R. Feyereisen, Y. Fujii-Kuriyama, F.J. Gonzalez, F P Guengerich, I.C. Gunsalus, E.F. Johnson, J.C. Loper, R. Sato, M.R. Waterman, and D.J. Waxman (1991) The P450 gene family: Update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 10:1-14.
33. Nef, P., J. Heidman, D. Lazard, T. Margalit, M. Jaye, I. Hanukoglu, and D. Lancet (1989) Olfactory-specific cytochrome P-450. J. Biol. Chem. 264 6780-6785
34. Nelson, D.R , T. Kamataki, D.J Waxman, F.P Guengerich, R.W. Estabrook, R. Feyereisen, F.J. Gonzalez, M J. Coon, I C Gunsalus, O. Gotoh, K. Okuda, and D.W. Nebert (1993) The P450 superfamily - update on new sequences, gene-mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12:1-51.
35. 3H]GBR-12935 binding proteins. Arch. Biochem Biophys. 276:424-432.
36. Norris, P.J., J.P. Hardwick, and P.C. Emson (1994) Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH-diaphorase staining. Neuroscience 61:331-350.
37. Ohta, S., O. Tachikawa, Y. Makino, Y Tasaki, and M. Hirobe (1990) Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal-model of a poor debrisoquine metabolizer. Life Sci. 46:599-605.
38. Pai, K.S., and V. Ravindranath (1991) Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducers: in vitro studies with brain slices. Brain Res. 555:239-244
39. Przuntek, H., H. Russ, K. Henning, and U. Pindur (1985) The protective effect of 1-tert, butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration causedby 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 37:1195-2000.
40. Ravindranath, V., H K. Anandatheerthavarada, and S.K. Shankar (1989) Xenobiotic metabolism in human brain - presence of cytochrome P-450 and associated mono-oxygenases. Brain Res. 496:331-335.
41. Russ, H., H. Prrzuntek, K. Henning, and U. Pindur (1986) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. New York: Academic Press.
42. Shahi, G.S , S.M. Moochhala, E.J.D. Lee, and N.P. Das (1989) Studies on the interactions of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) with the cytochrome P-450 enzyme system - clues to a possible aetiological factor in Parkinson's disease. Ann. Acad. Med. 18:93-97.
43. Skoda, R.C., F.J. Gonzalez, A. Demierre, and U.A. Meyer (1988) Two mutant alleles of the human cytochrome P-450db1 gene (P4502D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl. Acad. Sci U.S A 85:5240-5243.
44. Smith, C.A.D., A.C. Gough, P.N. Leigh, B.A. Summers, A.E. Harding, D.M. Maranganore, S.G. Sturman, A.H.V. Schapira, A.C. Williams, N.K. Spurr, and C.E. Wolf (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 339:1375-1377.
45. Suzuki, T., S. Fujita, S. Narimatsu, Y. Masubuchi, M. Tachibana, S. Ohta, and M Hirobe (1992) Cytochrome P450 isozymes catayzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroquinoline in rat liver microsomes. FASEB J. 6:771-776.
46. Swanson, L W (1992) Brain Maps: Structure of the Rat Brain. Amsterdam: Elsevier.
47. Tyndale, R.F , R Sunahara, T. Inaba, W. Kalow, F.J. Gonzalez, and H B. Niznik (1991) Neuronal cytochrome CYP2D1 (debrisoquine/sparteinetype): Potent inhibition of activity by (-)-cocaine and nucleotide sequence identity with human hepatic P450 gene CYP2D6. Mol Pharmacol. 40:63-68.
48. Warner, M., C. Köhler, T. Hansson, and J.-Å. Gustafsson (1988) Regional distribution of cytochrome P-450 in the rat brain: spectral quantification and contribution of P-450b,e and P-450c,d. J. Neurochem. 50.1057-1065.